Trademark applications and grants for H Lundbeck A S. H Lundbeck A S has 359 trademark applications. The latest application filed is for "LUNDBECK INSTITUTE"
Patent Application | Date |
---|---|
ANTI-MGLUR5 ANTIBODIES AND USES THEREOF 20220306734 - 17/629213 RAPORT; Carol J. ;   et al. | 2022-09-29 |
ANTI-PACAP ANTIBODIES AND USES THEREOF 20220289836 - 17/553280 LOOMIS; Maria-Cristina ;   et al. | 2022-09-15 |
ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS FOR USE IN EPILEPSY OR SEIZURES 20220280455 - 17/631762 Sams; Anette Graven ;   et al. | 2022-09-08 |
NEW CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE 20220257623 - 17/386686 Jensen; Klaus Gjervig ;   et al. | 2022-08-18 |
TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIESHEREOF 20220251178 - 17/608220 CADY; Roger K. ;   et al. | 2022-08-11 |
SEC | 0001188877 | H LUNDBECK A S |
SEC | 0001206828 | H LUNDBECK A S |
SEC | 0001549364 | H Lundbeck A/S / ADR of DENMARK |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.